Paul Edward Gross, See Remarks at Clovis Oncology, Inc. (CLVS), sold 466 shares at $14.59 ($7K) on 2019-12-03, disclosed to the SEC on 2019-12-05.
Open-market sale of $7k CLVS by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.59 | 212 | $3K | 45.5% |
| 2 | $14.59 | 254 | $4K | 54.5% |
| Total | $14.59 avg | 466 | $7K | 100% |
| Filing → |
| CLVS | SELL | 2022-08-03 | $7K | — | Filing → |
| CLVS | SELL | 2022-06-03 | $2K | — | Filing → |
| CLVS | SELL | 2022-05-03 | $9K | — | Filing → |